GW Henssler & Associates Ltd. acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 76,184 shares of the technology company's stock, valued at approximately $6,665,000. GW Henssler & Associates Ltd. owned about 0.06% of Amdocs as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOX. Central Pacific Bank Trust Division purchased a new position in shares of Amdocs during the 1st quarter worth $53,000. GAMMA Investing LLC lifted its position in Amdocs by 115.1% during the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company's stock worth $70,000 after buying an additional 428 shares during the period. American National Bank acquired a new stake in Amdocs in the 2nd quarter worth about $76,000. Blue Trust Inc. grew its holdings in Amdocs by 18.0% in the 2nd quarter. Blue Trust Inc. now owns 1,138 shares of the technology company's stock valued at $90,000 after buying an additional 174 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in Amdocs by 24.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,215 shares of the technology company's stock valued at $175,000 after buying an additional 440 shares during the period. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analysts Set New Price Targets
DOX has been the topic of several research analyst reports. StockNews.com raised shares of Amdocs from a "buy" rating to a "strong-buy" rating in a research report on Friday. Stifel Nicolaus started coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price target on the stock. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $102.00.
Get Our Latest Stock Analysis on Amdocs
Amdocs Trading Up 0.4 %
NASDAQ DOX traded up $0.34 during mid-day trading on Tuesday, hitting $88.63. The company's stock had a trading volume of 433,985 shares, compared to its average volume of 672,887. The firm has a market capitalization of $10.42 billion, a P/E ratio of 19.84, a price-to-earnings-growth ratio of 1.42 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The stock's fifty day simple moving average is $87.17 and its two-hundred day simple moving average is $83.57.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 7th. The technology company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.02. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.25 billion. During the same quarter in the previous year, the business posted $1.41 EPS. The business's quarterly revenue was up 1.1% on a year-over-year basis. Research analysts expect that Amdocs Limited will post 5.67 EPS for the current year.
Amdocs Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Monday, September 30th were issued a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend was Monday, September 30th. Amdocs's dividend payout ratio is presently 42.92%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
